For Consumers

Reopening of Comment Period: HIV-Focused Drug Development and HIV Cure Research

FDA is reopening the comment period for the notice of public meeting entitled “Human Immunodeficiency Virus (HIV) Patient-Focused Drug Development and HIV Cure Research,” published in the Federal Register of May 21, 2013. As part of Patient-Focused Drug Development, FDA is gathering input from HIV patients and patient advocates on current approaches to managing HIV, symptoms experienced because of HIV or its treatment, and patient perspectives related to "HIV cure research."

Comments can be submitted until September 3, 2013. Click here for more information and to submit comments.

Richard Klein
Office of Health and Constituent Affairs
Food and Drug Administration

Kimberly Struble
Division of Antiviral Products
Food and Drug Administration

Steve Morin
Office of Health and Constituent Affairs
Food and Drug Administration

Page Last Updated: 09/16/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.